Financials

Annual Reports

Financial Reports

Fiscal Year First Quarter Second Quarter Third Quarter Information Circular Financials & MD&A Annual Report

Filings

SEDAR View our filings as a publicly listed company in Canada (TSX).

EDGAR Our SEC filings as a publicly listed company in the United States (NASDAQ).

Analyst Coverage

Find out which analysts and institutions provide coverage of Oncolytics.

View Analyst Coverage

Latest News

October 24, 2014 Oncolytics Biotech® Inc. Announces Entry Into $20 Million "At-The-Market" Equity Distribution Agreement with Canaccord Genuity Inc.
October 20, 2014 Oncolytics Biotech® Inc. Announces Amendment to Common Share Purchase Agreement with Lincoln Park Capital Fund, LLC
September 16, 2014 Oncolytics Biotech® Inc. Announces Overall and KRAS-Mutated Patient Data from U.S. Randomized Phase 2 Pancreatic Cancer Study
Sign up to receive e-mail updates *